
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
<div>Lipid nanoparticles for targeted siRNA delivery – going from bench to bedside</div>
Victor Kotelianski, Timofei S. Zatsepin, Yuri Kotelevtsev
International Journal of Nanomedicine (2016) Vol. Volume 11, pp. 3077-3086
Open Access | Times Cited: 148
Victor Kotelianski, Timofei S. Zatsepin, Yuri Kotelevtsev
International Journal of Nanomedicine (2016) Vol. Volume 11, pp. 3077-3086
Open Access | Times Cited: 148
Showing 1-25 of 148 citing articles:
Lipid Nanoparticles─From Liposomes to mRNA Vaccine Delivery, a Landscape of Research Diversity and Advancement
Rumiana Tenchov, Robert E. Bird, Allison Curtze, et al.
ACS Nano (2021) Vol. 15, Iss. 11, pp. 16982-17015
Closed Access | Times Cited: 1324
Rumiana Tenchov, Robert E. Bird, Allison Curtze, et al.
ACS Nano (2021) Vol. 15, Iss. 11, pp. 16982-17015
Closed Access | Times Cited: 1324
Therapies for rare diseases: therapeutic modalities, progress and challenges ahead
Erik Tambuyzer, Benjamin Vandendriessche, Christopher P. Austin, et al.
Nature Reviews Drug Discovery (2019) Vol. 19, Iss. 2, pp. 93-111
Open Access | Times Cited: 268
Erik Tambuyzer, Benjamin Vandendriessche, Christopher P. Austin, et al.
Nature Reviews Drug Discovery (2019) Vol. 19, Iss. 2, pp. 93-111
Open Access | Times Cited: 268
Systemic delivery of factor IX messenger RNA for protein replacement therapy
Suvasini Ramaswamy, Nina Tonnu, Kiyoshi Tachikawa, et al.
Proceedings of the National Academy of Sciences (2017) Vol. 114, Iss. 10
Open Access | Times Cited: 261
Suvasini Ramaswamy, Nina Tonnu, Kiyoshi Tachikawa, et al.
Proceedings of the National Academy of Sciences (2017) Vol. 114, Iss. 10
Open Access | Times Cited: 261
siRNA therapeutics: a clinical reality
Phei Er Saw, Erwei Song
Science China Life Sciences (2019) Vol. 63, Iss. 4, pp. 485-500
Closed Access | Times Cited: 252
Phei Er Saw, Erwei Song
Science China Life Sciences (2019) Vol. 63, Iss. 4, pp. 485-500
Closed Access | Times Cited: 252
Gemcitabine loaded autologous exosomes for effective and safe chemotherapy of pancreatic cancer
Yongjiang Li, Junyong Wu, Jiemin Wang, et al.
Acta Biomaterialia (2019) Vol. 101, pp. 519-530
Closed Access | Times Cited: 243
Yongjiang Li, Junyong Wu, Jiemin Wang, et al.
Acta Biomaterialia (2019) Vol. 101, pp. 519-530
Closed Access | Times Cited: 243
The delivery challenge: fulfilling the promise of therapeutic genome editing
Joost van Haasteren, Jie Li, Olivia J. Scheideler, et al.
Nature Biotechnology (2020) Vol. 38, Iss. 7, pp. 845-855
Closed Access | Times Cited: 221
Joost van Haasteren, Jie Li, Olivia J. Scheideler, et al.
Nature Biotechnology (2020) Vol. 38, Iss. 7, pp. 845-855
Closed Access | Times Cited: 221
Non-viral Delivery of Nucleic Acids: Insight Into Mechanisms of Overcoming Intracellular Barriers
Mikhail Durymanov, Joshua Reineke
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 203
Mikhail Durymanov, Joshua Reineke
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 203
Current Development of siRNA Bioconjugates: From Research to the Clinic
Ivan V. Chernikov, Valentin V. Vlassov, E. L. Chernolovskaya
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 190
Ivan V. Chernikov, Valentin V. Vlassov, E. L. Chernolovskaya
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 190
Lipid-based nanoparticle formulations for small molecules and RNA drugs
Ludger M. Ickenstein, Patrick Garidel
Expert Opinion on Drug Delivery (2019) Vol. 16, Iss. 11, pp. 1205-1226
Closed Access | Times Cited: 166
Ludger M. Ickenstein, Patrick Garidel
Expert Opinion on Drug Delivery (2019) Vol. 16, Iss. 11, pp. 1205-1226
Closed Access | Times Cited: 166
Efficient nanocarriers of siRNA therapeutics for cancer treatment
Md Abdus Subhan, V. P. Torchilin
Translational research (2019) Vol. 214, pp. 62-91
Closed Access | Times Cited: 155
Md Abdus Subhan, V. P. Torchilin
Translational research (2019) Vol. 214, pp. 62-91
Closed Access | Times Cited: 155
Hydroxycholesterol substitution in ionizable lipid nanoparticles for mRNA delivery to T cells
Savan K. Patel, Margaret M. Billingsley, C. Pritchett Frazee, et al.
Journal of Controlled Release (2022) Vol. 347, pp. 521-532
Open Access | Times Cited: 75
Savan K. Patel, Margaret M. Billingsley, C. Pritchett Frazee, et al.
Journal of Controlled Release (2022) Vol. 347, pp. 521-532
Open Access | Times Cited: 75
Targeted tissue delivery of RNA therapeutics using antibody–oligonucleotide conjugates (AOCs)
Barbora Malecová, Rob S. Burke, Michael A. Cochran, et al.
Nucleic Acids Research (2023) Vol. 51, Iss. 12, pp. 5901-5910
Open Access | Times Cited: 57
Barbora Malecová, Rob S. Burke, Michael A. Cochran, et al.
Nucleic Acids Research (2023) Vol. 51, Iss. 12, pp. 5901-5910
Open Access | Times Cited: 57
Insights into the Structure of Comirnaty Covid-19 Vaccine: A Theory on Soft, Partially Bilayer-Covered Nanoparticles with Hydrogen Bond-Stabilized mRNA–Lipid Complexes
János Szebeni, Bálint Kiss, Tamás Bozó, et al.
ACS Nano (2023) Vol. 17, Iss. 14, pp. 13147-13157
Open Access | Times Cited: 46
János Szebeni, Bálint Kiss, Tamás Bozó, et al.
ACS Nano (2023) Vol. 17, Iss. 14, pp. 13147-13157
Open Access | Times Cited: 46
Journey of siRNA: Clinical Developments and Targeted Delivery
Rahul R. Nikam, Kiran R. Gore
Nucleic Acid Therapeutics (2018) Vol. 28, Iss. 4, pp. 209-224
Closed Access | Times Cited: 156
Rahul R. Nikam, Kiran R. Gore
Nucleic Acid Therapeutics (2018) Vol. 28, Iss. 4, pp. 209-224
Closed Access | Times Cited: 156
Potential applications and human biosafety of nanomaterials used in nanomedicine
Hong Su, Yafei Wang, Yuanliang Gu, et al.
Journal of Applied Toxicology (2017) Vol. 38, Iss. 1, pp. 3-24
Open Access | Times Cited: 152
Hong Su, Yafei Wang, Yuanliang Gu, et al.
Journal of Applied Toxicology (2017) Vol. 38, Iss. 1, pp. 3-24
Open Access | Times Cited: 152
Exosomes serve as nanoparticles to suppress tumor growth and angiogenesis in gastric cancer by delivering hepatocyte growth factor siRNA
Haiyang Zhang, Yi Wang, Ming Bai, et al.
Cancer Science (2017) Vol. 109, Iss. 3, pp. 629-641
Open Access | Times Cited: 130
Haiyang Zhang, Yi Wang, Ming Bai, et al.
Cancer Science (2017) Vol. 109, Iss. 3, pp. 629-641
Open Access | Times Cited: 130
Engineering functional inorganic–organic hybrid systems: advances in siRNA therapeutics
Jianliang Shen, Wei Zhang, Ruogu Qi, et al.
Chemical Society Reviews (2018) Vol. 47, Iss. 6, pp. 1969-1995
Open Access | Times Cited: 125
Jianliang Shen, Wei Zhang, Ruogu Qi, et al.
Chemical Society Reviews (2018) Vol. 47, Iss. 6, pp. 1969-1995
Open Access | Times Cited: 125
Targeting RNA : A Transformative Therapeutic Strategy
Wei Yin, Mark Rogge
Clinical and Translational Science (2019) Vol. 12, Iss. 2, pp. 98-112
Open Access | Times Cited: 125
Wei Yin, Mark Rogge
Clinical and Translational Science (2019) Vol. 12, Iss. 2, pp. 98-112
Open Access | Times Cited: 125
MicroRNAs Enable mRNA Therapeutics to Selectively Program Cancer Cells to Self-Destruct
Ruchi Jain, Josh P. Frederick, Eric Yi‐Hsiu Huang, et al.
Nucleic Acid Therapeutics (2018) Vol. 28, Iss. 5, pp. 285-296
Open Access | Times Cited: 120
Ruchi Jain, Josh P. Frederick, Eric Yi‐Hsiu Huang, et al.
Nucleic Acid Therapeutics (2018) Vol. 28, Iss. 5, pp. 285-296
Open Access | Times Cited: 120
Dendritic Cell Targeting mRNA Lipopolyplexes Combine Strong Antitumor T-Cell Immunity with Improved Inflammatory Safety
Kevin Van der Jeught, Stefaan De Koker, Lukasz Bialkowski, et al.
ACS Nano (2018) Vol. 12, Iss. 10, pp. 9815-9829
Open Access | Times Cited: 120
Kevin Van der Jeught, Stefaan De Koker, Lukasz Bialkowski, et al.
ACS Nano (2018) Vol. 12, Iss. 10, pp. 9815-9829
Open Access | Times Cited: 120
Lipid Delivery Systems for Nucleic-Acid-Based-Drugs: From Production to Clinical Applications
Anna Angela Barba, Sabrina Bochicchio, Annalisa Dalmoro, et al.
Pharmaceutics (2019) Vol. 11, Iss. 8, pp. 360-360
Open Access | Times Cited: 120
Anna Angela Barba, Sabrina Bochicchio, Annalisa Dalmoro, et al.
Pharmaceutics (2019) Vol. 11, Iss. 8, pp. 360-360
Open Access | Times Cited: 120
Treatment with mRNA coding for the necroptosis mediator MLKL induces antitumor immunity directed against neo-epitopes
Lien Van Hoecke, Sandra Van Lint, Kenny Roose, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 112
Lien Van Hoecke, Sandra Van Lint, Kenny Roose, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 112
Lipid nanoparticle-targeted mRNA therapy as a treatment for the inherited metabolic liver disorder arginase deficiency
Brian Truong, Gabriella Allegri, Xiaobo Liu, et al.
Proceedings of the National Academy of Sciences (2019) Vol. 116, Iss. 42, pp. 21150-21159
Open Access | Times Cited: 112
Brian Truong, Gabriella Allegri, Xiaobo Liu, et al.
Proceedings of the National Academy of Sciences (2019) Vol. 116, Iss. 42, pp. 21150-21159
Open Access | Times Cited: 112
Biomedical applications of mRNA nanomedicine
Qingqing Xiong, Gha Young Lee, Jianxun Ding, et al.
Nano Research (2018) Vol. 11, Iss. 10, pp. 5281-5309
Open Access | Times Cited: 110
Qingqing Xiong, Gha Young Lee, Jianxun Ding, et al.
Nano Research (2018) Vol. 11, Iss. 10, pp. 5281-5309
Open Access | Times Cited: 110
Improving siRNA DeliveryIn VivoThrough Lipid Conjugation
Maire F. Osborn, Anastasia Khvorova
Nucleic Acid Therapeutics (2018) Vol. 28, Iss. 3, pp. 128-136
Open Access | Times Cited: 105
Maire F. Osborn, Anastasia Khvorova
Nucleic Acid Therapeutics (2018) Vol. 28, Iss. 3, pp. 128-136
Open Access | Times Cited: 105